Contact Us   |   Sign In   |   Join
Treatment, Vaccines and Diagnostics


Potential Covid Vaccine Speeds Growth at Catalent


SAB Biotherapeutics Confirms Neutralizing Antibodies to SARS-CoV-2 and Begins Clinical Manufacturing of Novel

COVID-19 Therapeutic Candidate


Merck and Ridgeback Bio Collaborate to Advance Development of Novel Antiviral Candidate, EIDD-2801


AVI and Merck Collaborate to Develop Vaccine Against SARS-CoV-2


Merck to Apply its Industry-Leading Vaccine Development Capabilities to SARS-CoV-2 Vaccine Program Originated by

Themis and Institut Pasteur


Merck to Announce Multiple Scientific Efforts to Combat COVID-19


Contract for Covid-19 testing component will bring expansion, 300 jobs to Lenexa


COVID-19 study looks at genetics of healthy people who develop severe illness


MU researcher identifies four possible treatments for COVID-19


Global study to test malaria drug to protect health workers from COVID-19

Takeda, CSL-led alliance and NIH to test COVID-19 plasma treatment this summer


MRIGlobal To Deliver Three Mobile Medical Labs For Department Of Defense


Pfizer producing new Covid-19 vaccine for clinical trials at St. Louis County facility


Pfizer and BioNTECH dose first participants in the U.S. as part of global COVID-19 mRNA vaccine development program


Insight into FDA’s Revised Policy on Antibody Tests: Prioritizing Access and Accuracy


US allows use of 1st drug shown to help virus recovery




We need more covid-19 tests. We propose a ‘shark tank’ to get us there.


FDA allows Novartis to test hydroxychloroquine against COVID-19


NIH partners with 16 drug companies in hopes of accelerating Covid-19 treatments and vaccines


The race for antibodies


Pfizer Advances Battle Against COVID-19 on Multiple Fronts


Sanofi and GSK to join forces in unprecedented vaccine collaboration to fight COVID-19


Amgen And Adaptive Biotechnologies Announce Strategic Partnership To Develop A Therapeutic To Prevent Or Treat COVID-19


Johnson & Johnson and Award-Winning Journalist Lisa Ling Explore What It Takes to End a Pandemic


Possible COVID-19 treatment: transfusion of antibodies from recovered patients’ blood


Global Plasma Leaders Collaborate to Accelerate Development of Potential COVID-19 Hyperimmune Therapy


Area biotech works on treatment for lungs of COVID-19 patients


J&J picks top coronavirus vaccine candidate; human tests to start in September


Wash U gets FDA clearance to test a century-old idea on critical COVID-19 patients


Meet the SLU department on the frontlines of coronavirus vaccine development

Association Management Software Powered by YourMembership  ::  Legal